Anti-Doping Statistics of Turkisch Anti-Doping Commission for 2016 / Turkish Anti-Doping Commission (TADC). - Ankara : Türkiye Dopingle Mücadele Komisyonu (TDMK), 2017

Results of the WADA monitoring program regarding substances which are not on the 2016 Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.

These substances are:

In Competition Monitoring:
- Mitragynine
- Tramadol,

In and Out of Competition Monitoring:
- Telmisartan
- Glucocorticoids

Årsrapport 2016 Stiftelsen Antidoping Norge / Antidoping Norge. - Oslo : Antidoping Norge, 2017

Contents:

Årsberetning fra styret
1. Administrasjon og kommunikasjon
2. Dopingkontrollen
3. Forebyggende arbeid i idretten
4. Internasjonalt og medisinsk
5. Forskning og utvikling
6. Doping som samfunnsproblem

Annual Report 2016 / Anti-doping Authority Netherlands (Dopingautoriteit). - Capelle aan den IJssel : Dopingautoriteit, 2017

Contents:

Chapter 1 Prevention
- General
- Elite sports
- Sports organised outside a club context
- Support staff
- Sports associations
- General public
Chapter 2 Doping controls
Chapter 3 Intelligence & Investigations
Chapter 4 Disciplinary Proceedings
Chapter 5 International Affairs
Chapter 6 Legal Affairs
Chapter 7 Scientific research
Chapter 8 Knowledge Management
Chapter 9 People & organisation

NADA Annual Report 2016 / Nationale Anti Doping Agentur Deutschland (NADA). - Bonn : NADA, 2017

• NADA Material No. 63

KADA Annual Report 2015 / Korea Anti-Doping Agency (KADA). - Seoul : KADA, 2016

In 2015, the Korea Anti-Doping Agency (KADA) conducted a total number of 3,782 doping control tests (3,663 for urine, 119 for Blood).
Of those tests, 2,508 doping control tests were conducted on Korean Athletes under the Korea Anti-Doping Program funded by the government. The additional 1,274 user-pays tests were conducted on behalf of national and international sports organizations.

The proceedings of the 2017 Macolin Anti-Doping Summit : a fresh look at the science, legal and policy aspects of anti-Doping / Antonio Rigozzi, Emily Wisnosky, Brianna Quinn. - Bern. - Editions Weblaw, 2017. - ISBN 9783906836966

This book sets out the proceedings of the 2017 Macolin Anti-Doping Summit.

The Summit brought together many of the most experienced and knowledgeable specialists from various disciplines, encouraging open and thought-provoking discussions on each of the major facets of anti-doping (the science aspect, the legal aspect and the policy aspect), viewed through the lens of the 2015 World Anti-Doping Code in practice.

Speakers delved into issues as diverse as whether anti-doping science and regulation are keeping pace with doping, whether the law is jeopardising anti-doping efforts, the impact of the new emphasis on intelligence operations in anti-doping cases, what anti-doping can learn from the athlete?s perspective and the ethical challenges currently faced in anti-doping efforts.

Contents:

I. Introduction comments and acknowledgments
II. The <science> aspect
- 1. Session introduction: Professor Martial Saugy
- 2. A scientist's perspective: Professor David Cowan
- 3. A lawyer's perspective: Dr Marjolaine Viret
- 4. Panel discussion - Are anti-doping science and regulation keeping pace with doping?: Baron Dr Michel D'Hooghe, Dr Matthias Kamber, Dr Francesco Botre and Dr Peter Van Eenoo
III. The <legal> aspect
- 1. Session introduction: Mr Michele Bernasconi
- 2. Legal issues with minor athletes under the Code: Mr Herman Ram
- 3. Does the 2015 World Anti-Doping Code punish the <real cheaters> more harshly?: Ms Emily Wisnosky
- 4. Shifting the focus from testing to intelligence & investigations - Lessons learned: Mr Mathieu Holz
- 5. Addressing systematic failures within an anti-doping regime designed for individuals: Professor Ulrich Haas
- 6. Panel discussion - Is the law killing anti-doping efforts: Mr Michael Beloff QC, Mr Mike Morgan, Ms Brianna Quinn, Mr Jacques Radoux and Mr Mario Vigna
IV. The <policy> aspect
- 1. Session introduction: Professor Philippe Sands QC.
- 2. Overview of a current ethical challenge in anti-doping: Professor Andy Miah
- 3. Panel discussion - What can anti-doping learn from the athlete perspective?: Mr Obadele Thompson, Mr Johannes Eder and Mr Lucas Tramer
- 4. Psychological aspects of anti-doping - The decision to dope and the impact of getting caught: Dr Mattia Piffaretti
- 5. <Independence> of the anti-doping process - From the involvement of international federations to the role of CAS: Professor Antonio Rigozzi
- 6. Panel discussion - Outlook for the future of anti-doping: Full speed ahead or back to square one?: Mr Benjamin Cohen, Dr Paul Dimeo, Dr Bengt Kayser, Professor Denis Oswald and Mr Jaimie Fuller
V. Closing remarks

2015 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2017.
- Report compiled based on cases received by WADA before 31 January 2017

The World Anti-Doping Agency (WADA) has published its third annual Anti-Doping Rule Violations (ADRVs) Report, which is the first set of Anti-Doping Rule Violation statistics under the revised World Anti-Doping Code (Code). An ADRV is a doping offence committed by an athlete or athlete support person, which results in certain consequences or sanctions.

The Report illustrates doping offences committed in global sport during 2015. It highlights that there was a total of 1,929 ADRVs recorded in 2015, involving individuals from 122 nationalities and across 85 sports. 1,649 of the ADRVs were derived from adverse analytical findings (AAFs), commonly known as ‘positive’ results; these 1,649 ADRVs represented 65% of the total 2,522 AAFs that were reported by WADA-accredited laboratories. The remaining 280 non-analytical ADRVs were issued as a result of evidence-based intelligence; of which, 252 were committed by athletes and 28 by athlete support personnel. This represents an increase in non-analytical ADRVs, and is in line with the anti-doping movement’s increased focus on investigations, intelligence-gathering and whistleblowing.

Contents:

Introduction
Executive Summary
Section 1: Outcomes of 2015 AAFs by Sport Category
Section 2: Outcomes of 2015 AAFs by Testing Authority Category
Section 3: Report of 2015 Non-Analytical ADRVs
Section 4: Report of 2015 Total Analytical and Non-Analytical ADRVs